These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33947693)

  • 1. The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients.
    Zheng B; Liu XL; Fan R; Bai J; Wen H; Du LT; Jiang GQ; Wang CY; Fan XT; Ye YN; Qian YS; Wang YC; Liu GJ; Deng GH; Shen F; Hu HP; Wang H; Zhang QZ; Ru LL; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Kong F; Chen JM; Zheng D; Yang Y; Wang CX; Wu L; Hou JL; Liu JF; Wang HY; Chen L
    Clin Cancer Res; 2021 Jul; 27(13):3772-3783. PubMed ID: 33947693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of HBV DNA integration in plasma cell-free DNA of different HBV diseases utilizing DNA capture strategy.
    Yang Z; Zeng J; Chen Y; Wang M; Luo H; Huang AL; Deng H; Hu Y
    Virol Sin; 2024 Aug; 39(4):655-666. PubMed ID: 38852920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.
    Li CL; Ho MC; Lin YY; Tzeng ST; Chen YJ; Pai HY; Wang YC; Chen CL; Lee YH; Chen DS; Yeh SH; Chen PJ
    Hepatology; 2020 Dec; 72(6):2063-2076. PubMed ID: 32171027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.
    Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D
    Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
    Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
    Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difference of HBV DNA levels and HBV genotypes between the patients with primary hepatocellular carcinoma and liver cirrhosis with hepatitis B].
    Wang JH; Zhou M; Li Y; Deng J; Wu XX; Cheng W; Gu XB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):245-7. PubMed ID: 22097598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
    Mathkar PP; Chen X; Sulovari A; Li D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
    Qian Z; Liang J; Huang R; Song W; Ying J; Bi X; Zhao J; Shi Z; Liu W; Liu J; Li Z; Zhou J; Huang Z; Zhang Y; Zhao D; Wu J; Wang L; Chen X; Mao R; Zhou Y; Guo L; Hu H; Ge D; Li X; Luo Z; Yao J; Li T; Chen Q; Wang B; Wei Z; Chen K; Qu C; Cai J; Jiao Y; Bao L; Zhao H
    Gut; 2024 Jun; 73(7):1169-1182. PubMed ID: 38395437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma.
    Trung NT; Hoan NX; Trung PQ; Binh MT; Van Tong H; Toan NL; Bang MH; Song LH
    Sci Rep; 2020 May; 10(1):8181. PubMed ID: 32424223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.
    Datta S; Roychoudhury S; Ghosh A; Dasgupta D; Ghosh A; Chakraborty BC; Ray S; Gupta S; Santra AK; Datta S; Das K; Dhali GK; Chowdhury A; Banerjee S
    PLoS One; 2014; 9(7):e102573. PubMed ID: 25032957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
    Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
    Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.
    Yeh SH; Li CL; Lin YY; Ho MC; Wang YC; Tseng ST; Chen PJ
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):921-929. PubMed ID: 36690297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
    Chen YM; Wu SH; Qiu CN; Yu DJ; Wang XJ
    Braz J Med Biol Res; 2013 Jul; 46(7):614-22. PubMed ID: 23903686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.